Acute cardiac care & resuscitation

Outcomes with mechanical circulatory support devices among patients with mechanical complications of acute myocardial infarction

Eur Heart J Acute Cardiovasc CarePublished large observational analysis of acute myocardial infarction (AMI) hospitalizations

Authors' conclusion

In this large observational analysis of AMI hospitalizations, mechanical complications were rare and associated with very high in-hospital mortality. Although the use of MCS has increased, in-hospital mortality rates remain high even among patients who received MCS. Further investigations are needed to clarify the role of MCS devices among patients with mechanical complications of AMI.

Study context

Population
AMI admissions (ST-elevation and non-ST-elevation myocardial infarction) with mechanical complications (ventricular septal defect, free wall rupture, or papillary muscle rupture)(0.2%) of 4,450,219 AMI patients had a mechanical complication
Participants
7,025 admissions
Exposure
Those who received mechanical circulatory support (MCS) vs. those who did not
  • Those who received MCSn = 3,115
Outcome
MCS use trend
Follow-up
2016 to 2020
Methodological detailsNational Inpatient Sample, years 2016-20
  • National Inpatient Sample
  • Years 2016-20

Main finding

As reported in the abstract

MCS use in 2016

39.3%

MCS use in 2020

48.9%

Observational data: associations, not effects.

Further findings

In-hospital mortality

In-hospital mortality trend · 2016 vs. 2020

In-hospital mortality in 2016
36.9%
In-hospital mortality in 2020
43.4%
  • Ptrend = 0.75

In-hospital mortality

There was no significant difference in in-hospital mortality

Original publication

Outcomes with mechanical circulatory support devices among patients with mechanical complications of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. Published 14 March 2025. doi:10.1093/ehjacc/zuaf039

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.